Table 1.
Changes in neutrophils after the first pegfilgrastim administration (n = 21)a,b
| Day 0c,d | Day 14c,d | P value | |
|---|---|---|---|
| WBC | 5395 (2700–8500) | 10,838 (5500–19,200) | < 0.001 |
| Neutrophil rate | 57.3% (41.8–67.1) | 77.2% (59.2–84.2) | < 0.001 |
| Absolute neutrophil count | 3126 (1463–5542) | 8492 (3300–15,110) | < 0.001 |
| CRP | 0.10 (0.03–0.63) | 0.37 (0.02–1.45) | 0.011 |
aMean age was 49.8 (range 33–64). bAll patients were given dose-dense EC (E: epirubicin 90 mg/m2, C: cyclophosphamide 600 mg/m2) and pegfilgrastim (3.6 mg) was administered 1–3 days later. cThe day of the first dose-dense EC administration was counted as Day 0. dMean (range)